BridgeBio Oncology Therapeutics, Inc. (BBOT) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$145.82M | -80.3% |
| 2024 | -$80.86M | -193853.3% |
| 2023 | -$41.7K | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$145.82M | -80.3% |
| 2024 | -$80.86M | -193853.3% |
| 2023 | -$41.7K | — |